Literature DB >> 1310081

Hepatocyte membrane stabilization by prostaglandins E1 and E2: favorable effects on rat liver injury.

N Masaki1, Y Ohta, H Shirataki, I Ogata, S Hayashi, S Yamada, K Hirata, S Nagoshi, S Mochida, T Tomiya.   

Abstract

When prostaglandin (PG) E1 was continuously administered to rats from 24 hours before giving a dose of carbon tetrachloride, deranged serum glutamic pyruvic transaminase levels and prothrombin time were significantly reduced 12 hours after intoxication compared with controls. A similar effect of PGE1 was seen at 24 hours in D-galactosamine-intoxicated rats. Liver histology showed a comparable attenuation of injury in these rats. These results were consistent with reported effects of PGE2, suggesting that both prostaglandins may share a common pathway in protection against liver injury. When PGE1 or 16,16'-dimethyl PGE2 was added to the medium of primary cultured rat hepatocytes, lipid peroxidation-dependent killing of the cells by tert-butyl hydroperoxide was significantly attenuated without affecting the extent of malondialdehyde accumulation compared with controls. Both prostaglandins significantly reduced the extent of increased plasma membrane microviscosity of these cells assessed by 1-[4-(trimethyl-ammonio)phenyl]-6-phenyl-1,3,5-hexatriene. PGE1 and PGE2 may possess cytoprotective effects on liver parenchymal cells through stabilization of membrane microviscosity, which may contribute to protection against liver injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310081     DOI: 10.1016/0016-5085(92)90105-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

1.  Protective effects of prostaglandin E1 on hepatocytes.

Authors:  Xian-Ling Liu; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Beneficial effects of administering intraportal prostaglandin E1 postoperatively to hepatectomy patients with massive intraoperative blood loss.

Authors:  T Katsuramaki; M Mukaiya; K Yamashiro; H Kimura; R Denno; K Hirata
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  Prostaglandin E2 receptor EP4 agonist induces Bcl-xL and independently activates proliferation signals in mouse primary hepatocytes.

Authors:  Kojiro Kataoka; Yasuhiro Takikawa; Shi De Lin; Kazuyuki Suzuki
Journal:  J Gastroenterol       Date:  2005-06       Impact factor: 7.527

4.  The mechanism of hepatic graft protection against reperfusion injury by prostaglandin E1.

Authors:  H Itasaka; T Suehiro; S Wakiyama; K Yanaga; M Shimada; K Sugimachi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Effect of prostaglandin E1 on arterial ketone body ratio in hepatectomy.

Authors:  J Hayakawa; G Yoshida; Y Usuda
Journal:  J Anesth       Date:  1994-06       Impact factor: 2.078

6.  TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury.

Authors:  J Muntané; F J Rodríguez; O Segado; A Quintero; J M Lozano; E Siendones; C A Pedraza; M Delgado; F O'Valle; R García; J L Montero; M De La Mata; G Miño
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

7.  Inhibition of neutral sphingomyelinase decreases arachidonic acid mediated inflammation in liver ischemia-reperfusion injury.

Authors:  Mutay Aslan; Filiz Özcan; Hazal Tuzcu; Ebru Kıraç; Gulsum O Elpek
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

8.  Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure.

Authors:  Chi-Jen Chu; Ching-Chin Hsiao; Teh-Fang Wang; Cho-Yu Chan; Fa-Yauh Lee; Full-Young Chang; Yi-Chou Chen; Hui-Chun Huang; Sun-Sang Wang; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

9.  Attenuation of acetaminophen hepatitis by prostaglandin E2. A histopathological study.

Authors:  G L Monto; P J Scheuer; R L Hansing; A K Burroughs
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

10.  Use of prostaglandin I2 analog in treatment of massive hepatic necrosis associated with endothelial cell injury and diffuse sinusoidal fibrin deposition.

Authors:  K Fujiwara; S Mochida; A Ohno; M Arai; A Matsui; N Masaki; K Hirata; T Tomiya; M Yamaoka; S Nagoshi
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.